Source: CMS Medicare GLP-1 Bridge Program At a Glance: The Quick Facts IMPORTANT: Check This First This program is designed ONLY for weight loss
Retatrutide is not indicated for children, females who are pregnant or planning to become pregnant, or females who are breastfeeding, due to insufficient long-term safety data
The 79-year-old patient approved to receive retatrutide had previously been treated for a year with tirzepatide, the generic name for Eli Lillys Zepbound, STAT reported
Whats involved in that process
By the end, youll know exactly what steps to take to advocate for yourself and get the treatment thats right for you
TL;DR - What You Need to Know About FeelGood GLP-1 in 60 Seconds FeelGood GLP-1 is a telehealth platform connecting patients with licensed medical providers for evaluation and, when clinically appropriate, access to compounded GLP-1 injections starting at $149 per month - in a category where FDA formally proposed in April 2026 removing semaglutide and tirzepatide from the 503B outsourcing bulks list - with a public comment period open through June 2026
